Get the Daily Brief
Latest Biotech News
Advances in Nanopore and Soft Robotics Technologies
Engineering innovations include a novel solid-state nanopore sensing platform developed by University of Illinois researchers enabling label-free single-biomolecule detection, enhancing prospects...
Silver Anniversary Reflections on the Human Genome Project
The 25-year milestone of the Human Genome Project's first draft is marked by reflections from key figures, including Francis Collins and J. Craig Venter. Their insights highlight the...
Multiomics Proteomics Partnerships Accelerate Integrated Biology
The proteomics field is witnessing strategic partnerships aligning gene sequencing with advanced protein analysis technologies. Ultima Genomics collaborates with Olink Proteomics, leveraging...
FDA and Pharma Strategic Leadership and Regulatory Updates
Bristol Myers Squibb appoints Chris Shibutani, M.D., a former Goldman Sachs biotech analyst and practicing anesthesiologist, as EVP and Chief Strategy Officer to guide long-term strategy and...
Emerging Biotech Research and Innovation Highlights
Promising research spans biomaterial development to reverse heart aging by modulating extracellular matrix properties, and drone technology equipped with AI gas sensors to enable rapid detection...
Significant Biopharma Financing and Market Trends
Year-to-date biopharma financing continues robustly with significant funds raised in both public and private rounds, reflecting sustained investor interest despite industry layoffs. Market...
Sarepta halts Duchenne gene therapy amid patient deaths
Sarepta Therapeutics has suspended Elevidys shipments for non-ambulatory Duchenne muscular dystrophy patients following a second acute liver failure death. Both fatalities involved boys reliant on...
Anne Wojcicki’s nonprofit outbids Regeneron for 23andMe
Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, has won a bidding war to purchase most of 23andMe’s assets for $305 million. This new agreement...
Novel Parkinson’s biomarkers link perivascular fluid and nerve changes
Recent studies illuminate Parkinson’s disease pathology through peripheral nervous system insights and brain fluid dynamics. One cohort study detailed structural and functional alterations in...
FDA approves pembrolizumab for head and neck cancer perioperative use
The FDA has approved pembrolizumab as a perioperative treatment for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1. The decision follows the phase...
BMS names ex-Goldman biotech analyst as chief strategy officer
Bristol Myers Squibb has appointed Dr. Chris Shibutani, a physician and former senior biotech analyst at Goldman Sachs, as EVP and chief strategy officer. Shibutani's role will encompass long-term...
Innovations in multiomics partnerships accelerate proteomics integration
Multiomics integration is advancing, particularly via strategic partnerships rather than in-house development. Ultima Genomics collaborates with Olink Proteomics to merge sequencing with...
Human Genome Project’s 25th anniversary reflections and impact
Marking 25 years since the first draft announcement, leaders including Francis Collins and J. Craig Venter reflect on the landmark Human Genome Project (HGP). Collins applauds the global...
KalVista’s FDA on-demand HAE drug decision delayed
KalVista Pharmaceuticals announced that the FDA postponed its regulatory decision on the company’s on-demand oral therapy for hereditary angioedema. The delay is attributed to the agency’s heavy...
Innovative cooling technology targets data center energy consumption
UC San Diego engineers developed a fiber membrane that removes heat via passive evaporation for cooling electronics and data centers. Published in Joule, this method offers a low-energy...
Newly developed biomaterial reveals reversible heart ageing mechanisms
Researchers at the National University of Singapore engineered DECIPHER, a hybrid biomaterial mimicking heart extracellular matrix properties to study ageing effects. Their work reveals that...
Sarepta Pauses Duchenne Gene Therapy After Second Liver Failure Death
Sarepta Therapeutics halted its Duchenne muscular dystrophy gene therapy Elevidys shipments for non-ambulatory patients after a second death from acute liver failure. Both fatalities occurred in...
Anne Wojcicki’s Nonprofit Wins 23andMe Bid at $305 Million
Anne Wojcicki, co-founder and former CEO, successfully led a nonprofit bidding team to acquire 23andMe’s assets for $305 million, outbidding Regeneron. The deal includes strong commitments to...
FDA Postpones Decision on KalVista’s Hereditary Angioedema Drug
KalVista Pharmaceuticals announced an FDA delay in its oral on-demand hereditary angioedema drug approval due to agency resource constraints. The postponement disrupts the company's development...
Sarepta Halts Duchenne Gene Therapy Amid Second Patient Death
Sarepta Therapeutics has suspended shipments of its gene therapy Elevidys for Duchenne muscular dystrophy in non-ambulatory patients following a second fatal case of acute liver failure. Both...